Cargando…
HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life
Prevention of HIV-1 transmission at mucosal surfaces will likely require durable pre-existing mucosal anti-HIV-1 antibodies (Abs). Defining the ontogeny, specificities and potentially protective nature of the initial mucosal virus-specific B-cell response will be critical for understanding how to in...
Autores principales: | Yates, N L, Stacey, A R, Nolen, T L, Vandergrift, N A, Moody, M A, Montefiori, D C, Weinhold, K J, Blattner, W A, Borrow, P, Shattock, R, Cohen, M S, Haynes, B F, Tomaras, G D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663876/ https://www.ncbi.nlm.nih.gov/pubmed/23299618 http://dx.doi.org/10.1038/mi.2012.107 |
Ejemplares similares
-
Lack of IgA envelope-reactive antibody producing cells in terminal ileum in early and chronic HIV-1 infection
por: Trama, AM, et al.
Publicado: (2012) -
P04-48. HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after gp120 protein vaccination or chronic HIV-1 infection
por: Bonsignori, M, et al.
Publicado: (2009) -
P04-01. Simultaneous enumeration of HIV-1 gp41 Env-specific IgG and IgM antibody-secreting cells with a multiplex B-cell fluorospot assay
por: Bonsignori, M, et al.
Publicado: (2009) -
OA021-04. HIV-1 gp41 envelope MPER mutation altered epitope conformation in lipid and increased sensitivity to 2F5 and 4E10 neutralizing antibodies
por: Shen, X, et al.
Publicado: (2009) -
HIV-1 Envelope gp41 Broadly Neutralizing Antibodies: Hurdles for Vaccine Development
por: Verkoczy, Laurent, et al.
Publicado: (2014)